Enhancement of antibiotic activity against poly-drug resistant Mycobacterium tuberculosis by phenothiazines.
暂无分享,去创建一个
[1] J. Kristiansen,et al. The antibacterial effect of selected phenothiazines and thioxanthenes on slow-growing mycobacteria. , 2009, Acta pathologica, microbiologica, et immunologica Scandinavica. Section B, Microbiology.
[2] L. Amaral,et al. Comparative in vitro activity of phenothiazines against multidrug-resistant Mycobacterium tuberculosis. , 2000, International journal of antimicrobial agents.
[3] L. Amaral,et al. Phenothiazines: an alternative to conventional therapy for the initial management of suspected multidrug resistant tuberculosis. A call for studies. , 2000, International journal of antimicrobial agents.
[4] J. Moniz-Pereira,et al. Outbreak of multiple drug-resistant tuberculosis in Lisbon: detection by restriction fragment length polymorphism analysis. , 1999, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.
[5] N. Wengenack,et al. Evidence for differential binding of isoniazid by Mycobacterium tuberculosis KatG and the isoniazid-resistant mutant KatG(S315T). , 1998, Biochemistry.
[6] L. Amaral,et al. The potential management of resistant infections with non-antibiotics. , 1997, The Journal of antimicrobial chemotherapy.
[7] L. Amaral,et al. Inhibition of the respiration of multi-drug resistant clinical isolates of Mycobacterium tuberculosis by thioridazine: potential use for initial therapy of freshly diagnosed tuberculosis. , 1996, The Journal of antimicrobial chemotherapy.
[8] S. Dastidar,et al. Antimycobacterial activity of methdilazine (Md), an antimicrobic phenothiazine , 1993, APMIS : acta pathologica, microbiologica, et immunologica Scandinavica.
[9] P. H. Reddy,et al. Correlation between calmodulin-like protein, phospholipids, and growth in glucose-grown Mycobacterium phlei. , 1992, Canadian journal of microbiology.
[10] T. A. Venkitasubramanian,et al. Calmodulin-like activity in mycobacteria. , 1991, Indian journal of biochemistry & biophysics.
[11] S. Bradley,et al. Retardation of the Emergence of Isoniazid-Resistant Mycobacteria by Phenothiazines and Quinacrine , 1969, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.
[12] Braude Vi,et al. The antitubercular effect of aminazin , 1967 .
[13] R. Wise. A review of the mechanisms of action and resistance of antimicrobial agents. , 1999, Canadian respiratory journal.
[14] Lung Disease,et al. Anti-tuberculosis drug resistance in the world : the WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance , 1997 .
[15] A. J. Crowle,et al. Chlorpromazine: a drug potentially useful for treating mycobacterial infections. , 1992, Chemotherapy.
[16] M. Kamińska. [Role of chlorpromazine in the treatment of pulmonary tuberculosis in psychiatric patients]. , 1967, Folia medica Cracoviensia.
[17] V. S. Libenson,et al. [The antitubercular effect of aminazin]. , 1967, Biulleten' eksperimental'noi biologii i meditsiny.